RiceBran Technologies
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a RIBT research report →
Price Chart
About the company
RiceBran Technologies, along with its associated companies, functions as a specialized purveyor of ingredients. Its core business revolves around the development, processing, and distribution of premium, wholesome, and nutrient-rich products, sourced primarily from rice and other select small grains. The company adeptly transforms raw rice bran into stabilized rice bran (SRB) and subsequently into a suite of high-value derivative products.
- CEO
- Eric Tompkins
- IPO
- 2003
- Employees
- 35
- HQ
- Tomball, TX, US
Get TickerSpark's AI analysis on RIBT
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $2.00K
- P/E
- -0.00
- PEG
- 0.00
- P/S
- 0.00
- P/B
- -0.00
- EV/EBITDA
- -0.65
- Div Yield
- 0.00%
- Gross Margin
- -1.81%
- Op Margin
- -28.06%
- Net Margin
- -39.63%
- ROE
- -181.15%
- ROIC
- -235.02%
Latest fiscal year · YoY change
- Revenue
- $22.65M-15.0%
- Gross Profit
- $-411,000+46.1%
- Op Income
- $-6,355,000
- Net Income
- $-8,975,000-14.2%
- EPS
- $-1.28+9.9%
- OCF Growth
- +38.6%
- FCF Growth
- +30.9%
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- -1.40
- RSI (14)
- 48
- Avg Volume
- 651
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
RiceBran Technologies reported weaker first-quarter results as derivative-business pressure pushed the company to a gross loss, while management emphasized an ongoing strategic review with active interest in the assets.· May 11, 2023
- Revenue fell to $9.3 million, down 12.2% from $10.6 million a year ago.
- Gross loss was $300,000 versus gross profit of $500,000 in Q1 2022, driven by the added value derivatives business.
- SG&A was flat at $1.7 million as the company said it was aggressively managing expenses.
- Cash and equivalents were $3.4 million at March 31, 2023, down $500,000 from year-end due to operations and capex.
- The board said its strategic review is ongoing, with active interest in the company’s assets and multiple potential outcomes under evaluation.
First-quarter 2023 revenue was $9.3 million, down 12.2% from $10.6 million in the prior-year quarter. Gross loss was $300,000 versus gross profit of $500,000 in Q1 2022, and operating loss widened to $2 million from $1.2 million. Net loss was $2 million, or $0.31 per share, compared with $1.5 million, or $0.29 per share, last year; adjusted EBITDA loss was $1.2 million versus $400,000 in Q1 2022. SG&A expenses were $1.7 million, unchanged year over year, and cash and equivalents were $3.4 million at March 31, 2023, down $500,000 from December 31, 2022. The company did not provide next-quarter or full-year operating guidance, instead saying the board’s strategic review of alternatives is ongoing.
Peter Bradley framed the quarter around a broader strategic review rather than day-to-day operating progress. He said prior management strategies had not created sustainable scale to support the business’s fixed costs, which is why the board is exploring strategic alternatives, and he noted there is active interest in the company’s assets. On operations, he said milling performance held at the prior quarter’s level and that the Golden Ridge arrangement continued to improve results, while the MGI capacity upgrade was completed and fully online, creating a stronger platform for future growth.
William Keneally gave the financial results in detail: revenue of $9.3 million, gross loss of $300,000, SG&A of $1.7 million, operating loss of $2 million, net loss of $2 million, or $0.31 per share, and adjusted EBITDA loss of $1.2 million. He attributed the year-over-year decline mainly to the added value derivatives business, while noting SG&A was unchanged as expenses were being tightly managed. He also said cash and equivalents were $3.4 million at March 31, 2023, down $500,000 from December 31, 2022 because of cash used in operations and capital expenditure, and mentioned $300,000 of other income from restitution payments ordered by a federal court in 2012.
There was no analyst Q&A on the call. Management said it would not take questions because of the sensitive nature of the strategic review, and said the alternatives are at various stages of review. The main added context was that there is active interest in the assets and several possible outcomes are being evaluated, but no further details were provided.
The bull case from the call is that the board’s strategic review has progressed enough to attract active interest in the company’s assets, which could lead to value-creating alternatives. Operationally, management said milling performance held steady, Golden Ridge improved under the Gander Foods agreement, and MGI’s 50% capacity upgrade is now fully online, giving the company a better base for future growth.
The bear case is that revenue declined, the company moved to a gross loss, and adjusted EBITDA losses widened, with management blaming the added value derivatives business and internal processing challenges. Cash also fell to $3.4 million, and the company gave no forward guidance, instead highlighting uncertainty around the ongoing strategic review and its possible outcomes.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 95.1%
- Shares Outstanding
- 10.00M
- Float Shares
- 9.51M
of shares held by institutions
1 13F filers
Buy/sell ratio 0.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Advisor Group, Inc. | 30 | 0 |
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jan 3, 24 | Russell Georgina | other | 0 |
| Jan 3, 24 | Rosenthal Brent David | other | 0 |
| Jan 3, 24 | Rosenthal Brent David | other | 4,816 |
| Jan 3, 24 | CHEMEROW DAVID I. | other | 0 |
| Jan 3, 24 | CHEMEROW DAVID I. | other | 0 |
| Jan 3, 24 | CHEMEROW DAVID I. | other | 4,817 |
| Jan 3, 24 | Tompkins Eric | other | 0 |
| Jan 3, 24 | Tompkins Eric | other | 2,853 |
| Jan 3, 24 | Tompkins Eric | other | 1,422 |
| Jan 3, 24 | Flynn James P | other | 0 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our RIBT coverage
Recent articles, reports, and earnings notes.
No research on RIBT yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate RIBT report →SeoulCeuticals Announces Position as One of Few US Brands Sourcing Panax Ginseng, Rice Bran, Snail Mucin, and PDRN Directly from South Korea
newsfilecorp.com · Mar 3
RiceBran Technologies Sells Golden Ridge Milling Facility
accesswire.com · Jan 26
RiceBran Technologies Names Two New Independent Directors
accesswire.com · Jan 4
RiceBran Technologies Reports Third Quarter 2023 Results
accesswire.com · Dec 20
RiceBran Technologies Secures Investment from Funicular Funds, LP
accesswire.com · Dec 4
RiceBran Technologies to Hold Annual Shareholder Meeting on October 16, 2023
accesswire.com · Oct 10
RiceBran Technologies Reports Second Quarter 2023 Results
accesswire.com · Aug 21
RiceBran Technologies Adopts Tax Benefits Preservation Plan Designed to Protect the Availability of Its Tax Benefits
accesswire.com · Jul 6
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.